BioPorto A/S
BIOPOR
Kedudukan dalam Saham
#22680
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Harga Saham
$0.16512379
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$81.75M
Perubahan (1 hari)
-0.95%
Perubahan (1 tahun)
-42.67%
Negara
DK
Perdagangan BioPorto A/S (BIOPOR)
Kategori
Healthcare
Modal pasaran bagi BioPorto A/S(BIOPOR)
Modal Pasaran: $81.75M
Sehingga October 2026, BioPorto A/S mempunyai modal pasaran sebanyak $81.75M. Ini menjadikan BioPorto A/S syarikat ke-22680th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran BioPorto A/S dari 2019 hingga 2026
BIOPOR berbanding dengan 5 teratas yang paling popular stocks
